235 related articles for article (PubMed ID: 29081488)
1. Statin use is associated with a reduced risk of hepatocellular carcinoma recurrence after initial liver resection.
Kawaguchi Y; Sakamoto Y; Ito D; Ito K; Arita J; Akamatsu N; Kaneko J; Hasegawa K; Moriya K; Kokudo N
Biosci Trends; 2017 Nov; 11(5):574-580. PubMed ID: 29081488
[TBL] [Abstract][Full Text] [Related]
2. Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma.
Yang SY; Wang CC; Chen KD; Liu YW; Lin CC; Chuang CH; Tsai YC; Yao CC; Yen YH; Hsiao CC; Hu TH; Tsai MC
BMC Cancer; 2021 Jan; 21(1):70. PubMed ID: 33446127
[TBL] [Abstract][Full Text] [Related]
3. Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgery.
Khajeh E; Moghadam AD; Eslami P; Ali-Hasan-Al-Saegh S; Ramouz A; Shafiei S; Ghamarnejad O; Dezfouli SA; Rupp C; Springfeld C; Carvalho C; Probst P; Mousavizadeh SM; Mehrabi A
BMC Cancer; 2022 Jan; 22(1):91. PubMed ID: 35062904
[TBL] [Abstract][Full Text] [Related]
4. Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysis.
Khajeh E; Aminizadeh E; Moghadam AD; Ramouz A; Klotz R; Golriz M; Merle U; Springfeld C; Chang DH; Longerich T; Büchler MW; Mehrabi A
Cancer Med; 2023 Oct; 12(19):19548-19559. PubMed ID: 37737550
[TBL] [Abstract][Full Text] [Related]
5. Statin use is associated with better post-operative prognosis among patients with hepatitis B virus-related hepatocellular carcinoma.
Yun B; Ahn SH; Oh J; Yoon JH; Kim BK
Eur J Clin Invest; 2023 Apr; 53(4):e13936. PubMed ID: 36504405
[TBL] [Abstract][Full Text] [Related]
6. Impact of statin use on the prognosis of patients with hepatocellular carcinoma undergoing liver resection: a subgroup analysis of patients without chronic hepatitis viral infection.
Nishio T; Taura K; Nakamura N; Seo S; Yasuchika K; Kaido T; Okajima H; Hatano E; Uemoto S
Surgery; 2018 Feb; 163(2):264-269. PubMed ID: 29167018
[TBL] [Abstract][Full Text] [Related]
7. Anticancer Effect of Statins in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
Lee HL; Lee SW; Jang JW; Bae SH; Choi JY; Yoon SK; Choi HJ; Na GH; You YK; Park IY; Kim DG
Liver Transpl; 2022 Mar; 28(3):397-406. PubMed ID: 34374192
[TBL] [Abstract][Full Text] [Related]
8. Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients.
Cho Y; Kim MS; Nam CM; Kang ES
Sci Rep; 2019 Feb; 9(1):1467. PubMed ID: 30728421
[TBL] [Abstract][Full Text] [Related]
9. Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma.
Higashi T; Hayashi H; Kitano Y; Yamamura K; Kaida T; Arima K; Taki K; Nakagawa S; Okabe H; Nitta H; Imai K; Hashimoto D; Chikamoto A; Beppu T; Baba H
Med Oncol; 2016 Nov; 33(11):123. PubMed ID: 27734263
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence.
Lei J; Zhong J; Hao J; Liu Z; Zhang P; Wu L; Yan L; Zhu J; Zeng Y; Li B; Wen T; Wang W
Oncotarget; 2016 Jul; 7(27):42598-42607. PubMed ID: 26981887
[TBL] [Abstract][Full Text] [Related]
11. [The value of portal vein chemotherapy after radical resection in delaying intrahepatic recurrence of stage II primary hepatocellular carcinoma].
Zhang GQ; Ge L; Ding W; Li HJ
Ai Zheng; 2008 Dec; 27(12):1297-301. PubMed ID: 19079997
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients.
Xia F; Wu LL; Lau WY; Huan HB; Wen XD; Ma KS; Li XW; Bie P
World J Gastroenterol; 2016 Jun; 22(23):5384-92. PubMed ID: 27340354
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection.
Lee PC; Yeh CM; Hu YW; Chen CC; Liu CJ; Su CW; Huo TI; Huang YH; Chao Y; Chen TJ; Lin HC; Wu JC
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):874-883. PubMed ID: 27541812
[TBL] [Abstract][Full Text] [Related]
14. Administration of adjuvant oral tegafur/uracil chemotherapy post hepatocellular carcinoma resection: A randomized controlled trial.
Ishizuka M; Kubota K; Nemoto T; Shimoda M; Kato M; Iso Y; Tago K
Asian J Surg; 2016 Jul; 39(3):149-54. PubMed ID: 26123137
[TBL] [Abstract][Full Text] [Related]
15. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.
Yang T; Lu JH; Lau WY; Zhang TY; Zhang H; Shen YN; Alshebeeb K; Wu MC; Schwartz M; Shen F
J Hepatol; 2016 Mar; 64(3):583-93. PubMed ID: 26596543
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma After Hepatectomy.
Zou H; Zhu CZ; Wang C; Wang ZS; Ma X; Han B; Wu LQ
Am J Med Sci; 2017 Sep; 354(3):262-267. PubMed ID: 28918833
[TBL] [Abstract][Full Text] [Related]
17. Impact of pegylated interferon therapy on outcomes of patients with hepatitis C virus-related hepatocellular carcinoma after curative hepatic resection.
Tanimoto Y; Tashiro H; Aikata H; Amano H; Oshita A; Kobayashi T; Kuroda S; Tazawa H; Takahashi S; Itamoto T; Chayama K; Ohdan H
Ann Surg Oncol; 2012 Feb; 19(2):418-25. PubMed ID: 21710324
[TBL] [Abstract][Full Text] [Related]
18. Anatomical versus non-anatomical resection for solitary hepatocellular carcinoma without macroscopic vascular invasion: A propensity score matching analysis.
Zhao H; Chen C; Gu S; Yan X; Jia W; Mao L; Qiu Y
J Gastroenterol Hepatol; 2017 Apr; 32(4):870-878. PubMed ID: 27671209
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
20. Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection.
Tanaka K; Shimada H; Togo S; Takahashi T; Endo I; Sekido H; Yoshida T
Hepatogastroenterology; 1999; 46(26):1083-8. PubMed ID: 10370671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
